Reason: Under embargo until 3 October 2026. After this date a copy can be supplied under Section 51(2) of the Australian Copyright Act 1968 by submitting a document delivery request through your library
Development and optimisation of lymph-directing prodrugs to enhance oral drug exposure
thesis
posted on 2023-10-03, 04:18authored byXIAOTONG ZHOU
This thesis demonstrates the potential of utilising chemically modified drugs or prodrugs that target the lymphatic system to improve oral drug bioavailability. This approach has the potential to better address the challenges associated with inflammatory gut diseases and gut-related cancer therapy.